巨细胞病毒（CMV）疫苗研发的激动人心时刻：探寻保护婴儿免受先天性CMV感染这一目标的实现途径。
Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection.
作者信息
Schleiss Mark R, Diamond Don J
机构信息
Department of Pediatrics, Medical School Campus, University of Minnesota, Minneapolis, MN 55455, USA.
Department of Hematology/HCT, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
出版信息
Vaccines (Basel). 2020 Sep 14;8(3):526. doi: 10.3390/vaccines8030526.
Abstract
The congenital transmission of cytomegalovirus (cCMV) is the most common infectious cause of disability in children in the developed world, and probably globally [...].
摘要
巨细胞病毒的先天性传播（cCMV）是发达国家儿童残疾最常见的感染性病因，可能在全球范围内也是如此[……]
相似文献
1
Exciting Times for Cytomegalovirus (CMV) Vaccine Development: Navigating the Pathways toward the Goal of Protecting Infants against Congenital CMV Infection.巨细胞病毒（CMV）疫苗研发的激动人心时刻：探寻保护婴儿免受先天性CMV感染这一目标的实现途径。
Vaccines (Basel). 2020 Sep 14;8(3):526. doi: 10.3390/vaccines8030526.
2
Vaccine value profile for cytomegalovirus.巨细胞病毒的疫苗价值概况。
Vaccine. 2023 Nov 3;41 Suppl 2:S53-S75. doi: 10.1016/j.vaccine.2023.06.020. Epub 2023 Oct 6.
3
Inclusion of the Viral Pentamer Complex in a Vaccine Design Greatly Improves Protection against Congenital Cytomegalovirus in the Guinea Pig Model.将病毒五聚体复合物纳入疫苗设计可极大提高豚鼠模型中针对先天性巨细胞病毒的保护作用。
J Virol. 2019 Oct 29;93(22). doi: 10.1128/JVI.01442-19. Print 2019 Nov 15.
4
Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level.适度保护性的巨细胞病毒疫苗接种可有效预防儿童人群水平的先天性感染。
Vaccine. 2022 Aug 19;40(35):5179-5188. doi: 10.1016/j.vaccine.2022.07.026. Epub 2022 Jul 28.
5
Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection.先天性巨细胞病毒感染非人灵长类动物再感染模型中既往自然免疫的保护作用。
bioRxiv. 2023 Apr 10:2023.04.10.536057. doi: 10.1101/2023.04.10.536057.
6
Natural History of Congenital Cytomegalovirus Infection in Highly Seropositive Populations.高血清阳性人群中先天性巨细胞病毒感染的自然史
J Infect Dis. 2020 Mar 5;221(Suppl 1):S15-S22. doi: 10.1093/infdis/jiz443.
7
Priorities for CMV vaccine development.巨细胞病毒疫苗的开发重点。
Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13.
8
Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.使用巨细胞病毒高免疫球蛋白预防先天性巨细胞病毒病：回顾性分析。
J Perinat Med. 2012 Mar 27;40(4):439-46. doi: 10.1515/jpm-2011-0257.
9
Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study.母源性 IgG 抗体作为先天性巨细胞病毒感染的保护因素：一项母婴前瞻性队列研究。
EBioMedicine. 2022 Mar;77:103885. doi: 10.1016/j.ebiom.2022.103885. Epub 2022 Feb 18.
10
Short- and long-term impact of vaccination against cytomegalovirus: a modeling study.疫苗接种对抗巨细胞病毒的短期和长期影响：建模研究。
BMC Med. 2020 Jul 2;18(1):174. doi: 10.1186/s12916-020-01629-3.
引用本文的文献
1
Longitudinal observational research study: establishing the Australasian Congenital Cytomegalovirus Register (ACMVR).纵向观察性研究：建立澳大拉西亚先天性巨细胞病毒登记册（ACMVR）。
BMJ Open. 2025 Jun 25;15(6):e095636. doi: 10.1136/bmjopen-2024-095636.
2
Primary, Secondary, and Tertiary Prevention of Congenital Cytomegalovirus Infection.先天性巨细胞病毒感染的一级、二级和三级预防。
Viruses. 2023 Mar 23;15(4):819. doi: 10.3390/v15040819.
3
Diversity of the cochlear and vestibular pathologies in human temporal bones of newborns infected with cytomegalovirus.感染巨细胞病毒的新生儿人类颞骨中耳蜗和前庭病变的多样性。
Ann Clin Pathol. 2022;9(1). Epub 2022 Aug 29.
4
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development.从获得性天然免疫和临床试验中汲取经验教训，为下一代人巨细胞病毒疫苗的开发提供信息。
Annu Rev Virol. 2022 Sep 29;9(1):491-520. doi: 10.1146/annurev-virology-100220-010653. Epub 2022 Jun 15.
5
Modified vaccinia Ankara expressing EEHV1A glycoprotein B elicits humoral and cell-mediated immune responses in mice.改良安卡拉痘苗病毒表达 EHV-1A 糖蛋白 B 可在小鼠中引发体液和细胞介导的免疫应答。
PLoS One. 2022 Mar 21;17(3):e0265424. doi: 10.1371/journal.pone.0265424. eCollection 2022.
6
Clinical, Virologic and Immunologic Correlates of Breast Milk Acquired Cytomegalovirus (CMV) Infections in Very Low Birth Weight (VLBW) Infants in a Newborn Intensive Care Unit (NICU) Setting.在新生儿重症监护病房（NICU）环境中，极低出生体重（VLBW）婴儿通过母乳获得巨细胞病毒（CMV）感染的临床、病毒学和免疫学相关性。
Viruses. 2021 Sep 22;13(10):1897. doi: 10.3390/v13101897.
7
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice.抗人巨细胞病毒疫苗的研发：进展、障碍及对临床实践的启示
Vaccines (Basel). 2021 May 25;9(6):551. doi: 10.3390/vaccines9060551.
8
Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art.疫苗预防先天性巨细胞病毒感染：最新进展
Vaccines (Basel). 2021 May 19;9(5):523. doi: 10.3390/vaccines9050523.
9
Congenital Deafness and Recent Advances Towards Restoring Hearing Loss.先天性耳聋与听力损失修复的最新进展
Curr Protoc. 2021 Mar;1(3):e76. doi: 10.1002/cpz1.76.
本文引用的文献
1
Charting the life course: Emerging opportunities to advance scientific approaches using life course research.描绘生命历程：利用生命历程研究推进科学方法的新机遇。
J Clin Transl Sci. 2020 Jun 15;5(1):e9. doi: 10.1017/cts.2020.492.
2
The Status of Vaccine Development Against the Human Cytomegalovirus.人类巨细胞病毒疫苗的研发现状。
J Infect Dis. 2020 Mar 5;221(Suppl 1):S113-S122. doi: 10.1093/infdis/jiz447.
3
MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission.MVA载体五聚体复合物（PC）疫苗和gB疫苗可改善豚鼠巨细胞病毒攻击后的妊娠结局，但只有gB疫苗可减少垂直传播。
Vaccines (Basel). 2019 Nov 14;7(4):182. doi: 10.3390/vaccines7040182.
4
Vaccine Vectors Harnessing the Power of Cytomegaloviruses.利用巨细胞病毒力量的疫苗载体
Vaccines (Basel). 2019 Oct 17;7(4):152. doi: 10.3390/vaccines7040152.
5
Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas.中和性单克隆抗体可减少人巨细胞病毒在发育中的胎盘内的感染和传播。
Vaccines (Basel). 2019 Sep 29;7(4):135. doi: 10.3390/vaccines7040135.
6
Impact of Maternal Immunity on Congenital Cytomegalovirus Birth Prevalence and Infant Outcomes: A Systematic Review.母体免疫对先天性巨细胞病毒出生患病率及婴儿结局的影响：一项系统评价
Vaccines (Basel). 2019 Sep 26;7(4):129. doi: 10.3390/vaccines7040129.
7
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine.作为安全的人巨细胞病毒疫苗的五聚体阳性亚病毒致密体的生产策略。
Vaccines (Basel). 2019 Sep 1;7(3):104. doi: 10.3390/vaccines7030104.
8
Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening.先天性巨细胞病毒的认知与母婴筛查的接受度。
PLoS One. 2019 Aug 26;14(8):e0221725. doi: 10.1371/journal.pone.0221725. eCollection 2019.
9
..
Vaccines (Basel). 2019 Jul 22;7(3):70. doi: 10.3390/vaccines7030070.
10
From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.从疫苗载体到肿瘤调节：理解巨细胞病毒与癌症之间的复杂相互作用
Vaccines (Basel). 2019 Jul 9;7(3):62. doi: 10.3390/vaccines7030062.
Zotero 插件